Phase II Study of Nivolumab in Combination With Radiation Therapy as Definitive Treatment for Patients With Locally Advanced, Unresectable Head and Neck Mucosal Melanoma.
Samsung Medical Center
Samsung Medical Center
University of Texas Southwestern Medical Center
National Cancer Institute (NCI)
University of Michigan Rogel Cancer Center
Masonic Cancer Center, University of Minnesota
University of Utah
Northwestern University
OHSU Knight Cancer Institute